Structure |
Chemical Name |
CAS |
MF |
![Prasugrel Impurity 11](/) |
Prasugrel Impurity 11 |
|
|
![Trelagliptin Impurity 18](/) |
Trelagliptin Impurity 18 |
|
|
![Ropivacaine impurity](/CAS/20200611/GIF/1786560-34-6.gif) |
Ropivacaine impurity |
1786560-34-6 |
C12H14N2O3 |
![N-((3-(5-methyl-3-(4-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide](/CAS/20200331/GIF/CB14676620.gif) |
N-((3-(5-methyl-3-(4-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide |
|
C22H23N3O7S2 |
![(2R)-フェニルシクロペンチルヒドロキシ酢酸](/CAS/20211123/GIF/64471-45-0.gif) |
(2R)-フェニルシクロペンチルヒドロキシ酢酸 |
64471-45-0 |
C13H16O3 |
![2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5- (difluoromethoxy)-1Na-benzo[d]imidazole](/) |
2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5- (difluoromethoxy)-1Na-benzo[d]imidazole |
|
|
![(3S,3'S)-3,3'-((((4,4'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis (methylene))bis(4,1-phenylene))bis(oxy))bis(tetrahydrofuran)](/CAS/20200119/GIF/CB14713877.gif) |
(3S,3'S)-3,3'-((((4,4'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis (methylene))bis(4,1-phenylene))bis(oxy))bis(tetrahydrofuran) |
|
C34H32Cl2O4 |
![4-(1,3,2-Dioxaborinan-2-yl)benzonitrile](/CAS/20200331/GIF/152846-62-3.gif) |
4-(1,3,2-Dioxaborinan-2-yl)benzonitrile |
152846-62-3 |
C10H10BNO2 |
![Rasagiline Impurity 5 Mesylate](/CAS/20211123/GIF/1312077-04-5.gif) |
Rasagiline Impurity 5 Mesylate |
1312077-04-5 |
C13H15NO4S |
![Ibrutinib Dimer Impurity](/CAS/20200611/GIF/2031255-23-7.gif) |
Ibrutinib Dimer Impurity |
2031255-23-7 |
C50H48N12O4 |
![Rifaximin EP Impurity H](/CAS/20211123/GIF/1210022-90-4.gif) |
Rifaximin EP Impurity H |
1210022-90-4 |
C43H51N3O12 |
![Voriconazole (2R,3R)-Isomer](/CAS/20210111/GIF/137234-76-5.gif) |
Voriconazole (2R,3R)-Isomer |
137234-76-5 |
C16H13ClF3N5O |
![Diquafosol Impurity 12](/CAS/20210111/GIF/694434-51-0.gif) |
Diquafosol Impurity 12 |
694434-51-0 |
C18H26N4O23P4 |
![Etoricoxib Impurity 39](/CAS/20200515/GIF/107825-28-5.gif) |
Etoricoxib Impurity 39 |
107825-28-5 |
C13H17NOS2 |
![Furosemide Impurity 7](/CAS/20200119/GIF/4753-68-8.gif) |
Furosemide Impurity 7 |
4753-68-8 |
C5H8ClNO |
![Irinotecan Impurity 24](/CAS/20210111/GIF/802277-44-7.gif) |
Irinotecan Impurity 24 |
802277-44-7 |
C13H24N2O2 |
![Pyridoxine Impurity 12](/CAS/20200119/GIF/58947-70-9.gif) |
Pyridoxine Impurity 12 |
58947-70-9 |
C8H9NO3 |
![Thiamine](/CAS/20200119/GIF/6309-04-2.gif) |
Thiamine |
6309-04-2 |
C13H20Br2N4OS |
![1,1'-(1,4,8,11-tetraazacyclotetradecane-1,4-diyl)bis(2,2,2- trifluoroethan-1-one) dihydrochloride](/CAS/20200119/GIF/CB14797763.gif) |
1,1'-(1,4,8,11-tetraazacyclotetradecane-1,4-diyl)bis(2,2,2- trifluoroethan-1-one) dihydrochloride |
|
C14H24Cl2F6N4O2 |
![Empagliflozin Impurity 40](/) |
Empagliflozin Impurity 40 |
|
|
![Empagliflozin Impurity 46](/) |
Empagliflozin Impurity 46 |
|
|
![Mupirocin Impurity P/Decyl [2E,8[2S,3S(1S,2S)]]-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid Ester](/CAS/20200119/GIF/153900-96-0.gif) |
Mupirocin Impurity P/Decyl [2E,8[2S,3S(1S,2S)]]-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid Ester |
153900-96-0 |
C27H48O7 |
![pranoprofen](/CAS/20210111/GIF/143436-36-6.gif) |
pranoprofen |
143436-36-6 |
C17H19NO4 |
![2-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]Benzonitrile](/CAS/20200119/GIF/906673-30-1.gif) |
2-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]Benzonitrile |
906673-30-1 |
C14H10BNO3 |
![Fluconazole Impurity 5](/CAS/20200119/GIF/154534-83-5.gif) |
Fluconazole Impurity 5 |
154534-83-5 |
C10H9ClF2N4O |
![Fexofenadine N-Oxide](/CAS/20210111/GIF/1422515-52-3.gif) |
Fexofenadine N-Oxide |
1422515-52-3 |
C32H39NO5 |
![Trimetazidine Impurity 16](/CAS/20200611/GIF/118709-62-9.gif) |
Trimetazidine Impurity 16 |
118709-62-9 |
C13H16O4 |
![Ortho-Isomer of Dapagliflozin](/CAS/20210111/GIF/2040305-05-1.gif) |
Ortho-Isomer of Dapagliflozin |
2040305-05-1 |
C21H25ClO6 |
![Imidafenacin Related Compound 9](/CAS/20211123/GIF/170105-17-6.gif) |
Imidafenacin Related Compound 9 |
170105-17-6 |
C21H21N3 |
![Cefminox Sodium impurity 1](/) |
Cefminox Sodium impurity 1 |
|
|
![Dapagliflozin Impurity 5](/) |
Dapagliflozin Impurity 5 |
|
|
![Emtricitabine Impurity E](/) |
Emtricitabine Impurity E |
|
|
![Furosemide Impurity 4](/CAS/20200331/GIF/CB14812970.gif) |
Furosemide Impurity 4 |
|
C12H11ClN2O5S |
![Pitavastatin Impurity 43](/) |
Pitavastatin Impurity 43 |
|
|
![Tazobactam Impurity B](/CAS/20210111/GIF/158411-82-6.gif) |
Tazobactam Impurity B |
158411-82-6 |
C6H11NO3S |
![Tirofiban Impurity E](/) |
Tirofiban Impurity E |
|
|
![Tofacitinib Impurity 73](/) |
Tofacitinib Impurity 73 |
|
|
![(2R,3R)-2-アミノ-3-[4-(メチルスルホニル)フェニル]-1,3-プロパンジオール](/CAS/GIF/51458-28-7.gif) |
(2R,3R)-2-アミノ-3-[4-(メチルスルホニル)フェニル]-1,3-プロパンジオール |
51458-28-7 |
C10H15NO4S |
![21-(アセチルオキシ)-16α,17-ジヒドロキシプレグナ-1,4,9(11)-トリエン-3,20-ジオン](/CAS/GIF/77017-20-0.gif) |
21-(アセチルオキシ)-16α,17-ジヒドロキシプレグナ-1,4,9(11)-トリエン-3,20-ジオン |
77017-20-0 |
C23H28O6 |
![Pyrimidine, 4-chloro-5-nitro-2-(propylthio)-](/CAS/20210305/GIF/2518331-26-3.gif) |
Pyrimidine, 4-chloro-5-nitro-2-(propylthio)- |
2518331-26-3 |
C7H8ClN3O2S |
![Oseltamivir Impurity 110](/) |
Oseltamivir Impurity 110 |
|
|
![Warfarin Impurity 1](/CAS/20180703/GIF/55901-61-6.gif) |
Warfarin Impurity 1 |
55901-61-6 |
C13H14O |
![Macitentan impurity B](/CAS/20180808/GIF/441796-13-0.gif) |
Macitentan impurity B |
441796-13-0 |
C18H18Br2N6O4S |
![Meropenem IMP B](/) |
Meropenem IMP B |
|
|
![4-(6-ブロモピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル](/CAS/GIF/412348-27-7.gif) |
4-(6-ブロモピリジン-3-イル)ピペラジン-1-カルボン酸TERT-ブチル |
412348-27-7 |
C14H20BrN3O2 |
![(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid](/CAS/20180703/GIF/1012341-56-8.gif) |
(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid |
1012341-56-8 |
C23H29NO4 |
![Linagliptin Impurity D](/CAS/20200611/GIF/666816-91-7.gif) |
Linagliptin Impurity D |
666816-91-7 |
C20H28N6O4 |
![Parecoxib Impurity C](/CAS/20240320/GIF/3026677-40-4.gif) |
Parecoxib Impurity C |
3026677-40-4 |
|
![RAC アトモキセチン塩酸塩](/CAS/GIF/82857-40-7.gif) |
RAC アトモキセチン塩酸塩 |
82857-40-7 |
C17H22ClNO |
![3-(1H-imidazol-1-yl)-5-(trifluoromethyl)aniline](/CAS/20180703/GIF/943320-48-7.gif) |
3-(1H-imidazol-1-yl)-5-(trifluoromethyl)aniline |
943320-48-7 |
C10H8F3N3 |
![Linagliptin Impurity H](/CAS/20180808/GIF/1646355-34-1.gif) |
Linagliptin Impurity H |
1646355-34-1 |
C22H23N7O2 |
![Ezetimibe Impurity 54](/CAS/20180703/GIF/1185883-39-9.gif) |
Ezetimibe Impurity 54 |
1185883-39-9 |
C40H36F2N2O5 |
![2-(2-fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol](/CAS/20180703/GIF/1348664-75-4.gif) |
2-(2-fluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol |
1348664-75-4 |
C13H13FN6O |
![Dapagliflozin Impurity 2](/) |
Dapagliflozin Impurity 2 |
|
|
![Oseltamivir Impurity 108](/) |
Oseltamivir Impurity 108 |
|
|
![Oseltamivir Impurity 102](/) |
Oseltamivir Impurity 102 |
|
|
![1H-Pyrazole-1-propanenitrile, 4-(6-amino-5-formyl-4-pyrimidinyl)-β-cyclopentyl-, (βR)-](/CAS/20211123/GIF/2606144-45-8.gif) |
1H-Pyrazole-1-propanenitrile, 4-(6-amino-5-formyl-4-pyrimidinyl)-β-cyclopentyl-, (βR)- |
2606144-45-8 |
C16H18N6O |
![4-Piperidinecarboxylic acid, 1-(4-pyridinylcarbonyl)-, ethyl ester](/CAS/20210305/GIF/252263-38-0.gif) |
4-Piperidinecarboxylic acid, 1-(4-pyridinylcarbonyl)-, ethyl ester |
252263-38-0 |
C14H18N2O3 |
![1,4-ビス(4-ニトロフェニル)ピペラジン](/CAS/GIF/16264-05-4.gif) |
1,4-ビス(4-ニトロフェニル)ピペラジン |
16264-05-4 |
C16H16N4O4 |
![ビス(2,4-キシリル)ペルスルフィド](/CAS/GIF/13616-83-6.gif) |
ビス(2,4-キシリル)ペルスルフィド |
13616-83-6 |
C16H18S2 |
![バモロロン](/CAS/GIF/13209-41-1.gif) |
バモロロン |
13209-41-1 |
C22H28O4 |
![N-[(6-アミノ-1,2,3,4-テトラヒドロ-1,3-ジメチル-2,4-ジオキソピリミジン)-5-イル]ホルムアミド](/CAS/GIF/7597-60-6.gif) |
N-[(6-アミノ-1,2,3,4-テトラヒドロ-1,3-ジメチル-2,4-ジオキソピリミジン)-5-イル]ホルムアミド |
7597-60-6 |
C7H10N4O3 |
![3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/CAS/20211123/GIF/2374700-40-8.gif) |
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile |
2374700-40-8 |
C16H20N6O |
![7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI)](/CAS/20210305/GIF/129815-82-3.gif) |
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-2-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)- (9CI) |
129815-82-3 |
C18H20FN3O4 |
![Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]-](/CAS/20210305/GIF/769083-63-8.gif) |
Piperazine, 1-[2-[(4-methoxyphenyl)methyl]-4-methylphenyl]- |
769083-63-8 |
C19H24N2O |
![N,N'-ジイソプロピル尿素](/CAS/GIF/4128-37-4.gif) |
N,N'-ジイソプロピル尿素 |
4128-37-4 |
C7H16N2O |
![Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester](/CAS/20210305/GIF/141354-54-3.gif) |
Acetic acid, 2-[(5-bromo-2-pyridinyl)amino]-2-oxo-, ethyl ester |
141354-54-3 |
C9H9BrN2O3 |
![monocalcium mono((3R,5S,E)-7-(4-(3-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate)](/) |
monocalcium mono((3R,5S,E)-7-(4-(3-fluorophenyl)-6-isopropyl-2- (N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6- enoate) |
|
|
![Cefradine Impurity J](/) |
Cefradine Impurity J |
|
|
![Peramivir diacetyl impurity 1](/) |
Peramivir diacetyl impurity 1 |
|
|
![Urapidil Impurity 17](/) |
Urapidil Impurity 17 |
|
|
![Clindamycin Impurity 86](/) |
Clindamycin Impurity 86 |
|
|
![Canagliflozin Impurity 77](/) |
Canagliflozin Impurity 77 |
|
|
![Carbazochrome Sodium Sulfonate Impurity I](/) |
Carbazochrome Sodium Sulfonate Impurity I |
|
|
![NA](/) |
NA |
|
|
![NA](/) |
NA |
|
|
![Cetrorelix Impurity 18](/) |
Cetrorelix Impurity 18 |
|
|
![Cetrorelix Impurity 13](/) |
Cetrorelix Impurity 13 |
|
|
![NA](/) |
NA |
|
|
![Cetrorelix Impurity 2 (+L-Ser)](/) |
Cetrorelix Impurity 2 (+L-Ser) |
|
|
![Peramivir Intermediate Impurity 39](/) |
Peramivir Intermediate Impurity 39 |
|
|
![Peramivir Intermediate Impurity 59](/) |
Peramivir Intermediate Impurity 59 |
|
|
![Criborole impurity 999](/) |
Criborole impurity 999 |
|
|
![NA](/) |
NA |
|
|
![Bimatoprost Impurity 2](/) |
Bimatoprost Impurity 2 |
|
|
![Imatinib Impurity 1](/) |
Imatinib Impurity 1 |
|
|
![Imatinib Impurity 6](/) |
Imatinib Impurity 6 |
|
|
![Nifedipine Impurity 3](/CAS/20200401/GIF/CB83049910.gif) |
Nifedipine Impurity 3 |
|
C19H22N2O6 |
![Riociguat Impurtiy 5](/) |
Riociguat Impurtiy 5 |
|
|
![Vonoprazan Impurity 6](/) |
Vonoprazan Impurity 6 |
|
|
![Citalopram EP Impurity E](/CAS/20211123/GIF/64169-47-7.gif) |
Citalopram EP Impurity E |
64169-47-7 |
C19H22Cl2FNO |
![Dapagliflozin Impurity F](/) |
Dapagliflozin Impurity F |
|
|
![Dapoxetine Impurity A](/) |
Dapoxetine Impurity A |
|
|
![(1R,3S,4S)-エンテカビル](/CAS/20180808/GIF/1333204-94-6.gif) |
(1R,3S,4S)-エンテカビル |
1333204-94-6 |
C12H15N5O3 |
![Gadobutrol Impurity](/) |
Gadobutrol Impurity |
|
|
![Pramipexole Impurity G](/) |
Pramipexole Impurity G |
|
|
![SALMETEROL RELATED COMPOUND A (4-[1-ヒドロキシ-2-(4-フェニルブチルアミノ)エチル]-2-(ヒドロキシメチル)フェノール)](/CAS/20180703/GIF/1798014-51-3.gif) |
SALMETEROL RELATED COMPOUND A (4-[1-ヒドロキシ-2-(4-フェニルブチルアミノ)エチル]-2-(ヒドロキシメチル)フェノール) |
1798014-51-3 |
C19H25NO3 |
![Tacrolimus impurity D](/) |
Tacrolimus impurity D |
|
|
![2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole](/CAS/20180703/GIF/202189-77-3.gif) |
2-(2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)propan-2-yl)-4,4-dimethyl-4,5-dihydrooxazole |
202189-77-3 |
C32H44N4O2 |
![Saxagliptin Impurity 6](/) |
Saxagliptin Impurity 6 |
|
|